NEW YORK, Jan. 29 Reportlinker.com announces that a new market research report is available in its catalogue:
Coronary Stents - Global Market Trends
Advertisement
http://www.reportlinker.com/p0164222/Coronary-Stents---Global-Market-Trends.html
Aging population, enhanced availability of sophisticated stents, rising patient affluence and affordability, and growing awareness are factors propelling growth of coronary stents. Advances in technology and novel formulations from new market entrants, have significantly contributed to market growth. Thorny regulatory barriers in certain countries such as Japan continue to plague the industry leading to higher product prices. Improvement in cardiac care resulting in greater number of positive outcomes of coronary stenting will also lead to market expansion.
Advertisement
These and other market data and trends are presented in "Coronary Stents: Global Market Trends" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
CORONARY STENTS BMR-1022
CONTENTS
1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3
2. GLOBAL MARKET OVERVIEW 4
Drug Eluting Stents Steal the Show 4
Cypher and Taxus Dominate Global DES Market 4
A 10-Year Outlook for the Coronary Stents Industry 5
3. MARKET TRENDS AND ISSUES 6
Drug Eluting Stent System - Safety Concerns 6
Drug Eluting Stent Market to Bounce Back 6
Coronary Stents Market Challenged by Drug Therapy 7
Restenosis - the Real Growth Driver 7
Small Vessels - A Major Cause of Restenosis 7
Aging Population Propels Coronary Stent Market 8
Cell Transplantation - A Major Threat to Coronary Stents 8
Next Generation Stents - A Boon for Treating Coronary Diseases 8
Direct Stenting Systems Spur Growth 9
Drug Choice Impacts Market Entry 9
Price and Quality Concerns Dog Supplies and Demand for DES 9
DES' Introduction Skyrockets Coronary Stent Prices 10
Legal Challenges Right Behind 10
New Competition Puts Tabs on Coronary Stenting 10
4. COMPETITIVE ANALYSIS 10
5. PRODUCT FACTS 12
Bare Metal Stents 12
Major Bare Metal Stents by Company 12
Drug Eluting Stents 12
Major Drug-Eluting Stents by Company 13
A Peek into Regulatory Approvals for Coronary Stents 13
6. RESEARCH AND DEVELOPMENT 14
Extensive R&D Underway in Global Drug- Eluting Stents Market 14
At the Labs 14
Other Products Under Trials - A Recent Past Perspective 15
OMT Developing R-stent 15
Reva Developing Stainless Steel Bare- Metal Stent 15
D & P Corp Developing Bovine Pericardium - Covered Stent 15
Advanced Bio Synthesizing Porous Drug - Eluting Stents 15
Lombard Medical Developing PEP Coatings 16
Shiga Develops Biodegradable Drug- Eluting Stent 16
7. CORPORATE DEVELOPMENTS 16
Medtronic Receives the US FDA Approval to Use Endeavor® Stent 16
Medtronic Inc. Receives Approval for its Drug- Eluting Stent,
"Endeavor" In Canada 16
Boston Scientific to Market TAXUS® Liberte® Stent System in
Canada 17
Abbott Applies for Approval of XIENCE(TM) V in Japan 17
Medinol Achieves CE Mark Approval for Presillion(TM) Cobalt
Chromium Coronary Stent System 17
Iberhospitex Receives Spanish Approval to Sell Palau Pharma's
"Active" Coronary Stent 18
Clearstream's Intrepide Drug Eluting Stent of Clearstream
Receives CE mark approval 18
Terumo Introduces Its Drug-Eluting Stent in Germany and Marks
Its European Entry 18
Tryton Medical's Side-Branch Stent Achieves CE Mark Approval 18
CV Therapeutics Offers its Stent Coating Technology to
Medlogics Device Corporation 18
Abbott's 2.25mm-Sized XIENCE(TM) V Drug Eluting Stent receives
CE Mark of Approval 19
Biosensors Receives CE Mark Approval For BioMatrix® Stent System 19
Nfocus Neuromedical's CardioVasc(TM) Stent-Graft and Delivery
System Receives CE Mark Approval 19
InspireMD - MGuard(TM) Coronary Stent Launched in Italy 20
CeloNova BioSciences Launches CATANIA(TM) Coronary Stent with
Nano Thin Polyzene®-F 20
Angiotech Launches Cook Medical's Drug Eluting Zilver® PTX(TM)
Stent in New Zealand 20
Cook Medical's Zilver Stent Receives Approval for Vascular Use
In Canada 21
Boston Scientific to Market TAXUS® EXPRESS2 Stent System in Japan 21
CE Mark Granted for the Use of Drug-eluting Stent, TAXUS®
Liberte(TM) in Diabetic Patients 21
Boston Scientific's TAXUS® Liberte(TM) Long Stent Receives CE
Mark Approval 21
Boston Scientific Launches Its Own Version of XIENCE(TM)V Drug-
Eluting Coronary Stent in Europe 22
8. CLINICAL TRIALS AND KEY STUDIES 22
Canadian Study Indicates Superior Clinical Benefits of Drug-
Coated Stent 22
SPIRIT III Trial Confirms Superiority of Everolimus Eluting
Coronary Stent, XIENCE(TM) V Over TAXUS® Stent 22
Network Meta-Analysis Demonstrates Low Mortality Rates for
Both Drug-Eluting And Bare-Metal Stents 23
Study Proves Superiority of Cypher® Sirolimus-Eluting Coronary
Stent in Reduction of Blood Clot Risks and Reintervention
Compared to Taxus Stent 23
9. MAJOR PLAYERS 24
Angiotech Pharmaceuticals (Canada) 24
Boston Scientific Corp. (USA) 24
Cordis Corporation (JNJ) - (USA) 24
Cook Group, Inc. (USA) 25
Medtronic, Inc. (USA) 25
Medtronic Cardiovascular, Inc. (USA) 25
MIVI Technologies Inc. (Canada) 25
OrbusNeich (USA) 25
Sorin Biomedica Cardio (Italy) 26
Sun Biomedical Ltd. (USA) 26
10. MARKET ANALYTICS 27
11. THE UNITED STATES 33
Coronary Artery Disease - A US Perspective 33
Rapid Adoption of DES Technology in the US Market 33
Baby Boomers Boost Coronary Stent Market 33
Key Drivers of the US DES Market 34
Improved Treatment and Diagnosis 34
Long-Term Cost Reduction 34
Well-Organized Reimbursement System 34
Growing Patient Awareness 34
DES Technology - Economic Implications on the US Health Care
System 35
Soaring Costs of Multivessel Treatment - Still a Major Problem 35
Competitive Scenario 35
Leading Players 35
Coronary Stents - Boston Scientific and JNJ Battle for
Dominance 35
Regulatory Environment 37
12. JAPAN 39
Prospects Weighed down by Regulatory Entanglements 39
Japanese Government Steps in to Alleviate Pricing 39
Japanese Coronary Stents Command Higher Prices 39
Competitive Landscape 40
13. EUROPE 43
a. France 49
b. Germany 51
c. Italy 53
d. The United Kingdom 54
e. Spain 56
f. Russia 58
g. Rest of Europe 59
14. ASIA-PACIFIC 61
Coronary Stent Market in a Bubble Zone Now 61
Regional Players and their DES Development Efforts 61
Cost Focus Helps Stent Makers Win the Market Stunt 62
15. REST OF WORLD 63
Market Leaders 64
South Africa - Leading Players 64
EXHIBITS
Table 1: Growth in Angioplasty Procedures Vs Stent Penetration
Worldwide: (2006)
Table 2: Percentage Breakdown of Leading Coronary Stents
Manufacturer Revenues in the World - 2008
Table 3: Percentage Breakdown of Leading Bare Metal Stents
Manufacturer Revenues in the World - 2008
Table 4: Percentage Breakdown of Leading Drug-Eluting Stent
Manufacturer Revenues in the World - 2008
Table 5: Global Coronary Stents Market by Region for the
Period 2007-2015 (Sales in US$ Million)
Table 6: Percentage Breakdown (Dollar Sales) of Global
Coronary Stents Market by Region for the Years 2008 & 2012
Table 7: Global Coronary Stents Market by Region for the
Period 2007-2015 (Sales in Thousand Units)
Table 8: Percentage Breakdown (Unit Sales) of Global Coronary
Stents Market by Region for the Years 2008 & 2012
Table 9: Global Bare Metal Stents Market by Region for the
Period 2007-2015 (Sales in US$ Million)
Table 10: Percentage Breakdown (Dollar Sales) of Global Bare
Metal Stents Market by Region for the Years 2008 & 2012
Table 11: Global Bare Metal Stents Market by Region for the
Period 2007-2015 (Sales in Thousand Units)
Table 12: Percentage Breakdown (Unit Sales) of Global Bare
Metal Stents Market by Region for the Years 2008 & 2012
Table 13: Global Drug Eluting Stents Market by Region for the
Period 2007-2015 (Sales in US$ Million)
Table 14: Percentage Breakdown (Dollar Sales) of Global Drug
Eluting Stents Market by Region for the Years 2008 & 2012
Table 15: Global Drug Eluting Stents Market by Region for the
Period 2007-2015 (Sales in Thousand Units)
Table 16: Percentage Breakdown (Unit Sales) of Global Drug
Eluting Stents Market by Region for the Years 2008 & 2012
Table 17: Percentage Breakdown of Leading Coronary Stents
Manufacturer Revenues in the US - 2006
Table 18: Percentage Breakdown of Leading Bare Metal Stents
Manufacturer Revenues in the US - 2006
Table 19: Percentage Breakdown of Leading Drug-Eluting Stents
Manufacturer Revenues in the US - 2008
Table 20: Coronary Stents Market by Segment in the US:
2007-2015 (Sales in US$ Million)
Table 21: Percentage Breakdown (Dollar Sales) of Coronary
Stents Market by Segment in the US for the Years 2008 & 2012
Table 22: Coronary Stents Market by Segment in the US:
2007-2015 (Sales in Thousand Units)
Table 23: Percentage Breakdown (Unit Sales) of Coronary Stents
Market by Segment in the US for the Years 2008 & 2012
Table 24: Comparative Analysis of Coronary Stent Prices - 2008
Table 25: Percentage Breakdown of Leading Coronary Stent
Manufacturer Value Sales in Japan - 2006
Table 26: Percentage Breakdown of Leading Bare Metal Stent
Manufacturer Value Sales in Japan - 2006
Table 27: Percentage Breakdown of Leading Drug-Eluting Stent
Manufacturer Value Sales in Japan - 2008
Table 28: Coronary Stents Market by Segment in Japan:
2007-2015 (Sales in US$ Million)
Table 29: Percentage Breakdown (Dollar Sales) of Coronary
Stents Market by Segment in Japan for the Years 2008 & 2012
Table 30: Coronary Stents Market by Segment in Japan:
2007-2015 (Sales in Thousand Units)
Table 31: Percentage Breakdown (Unit Sales) of Coronary Stents
Market by Segment in Japan for the Years 2008 & 2012
Table 32: Percentage Breakdown of Leading Bare Metal Stent
Manufacturer Value Sales in Europe - 2006
Table 33: Percentage Breakdown of Leading Drug-Eluting Stent
Manufacturer Value Sales in Europe - 2006
Table 34: Coronary Stents Market by Region in Europe:
2007-2015 (Sales in US$ Million)
Table 35: Percentage Breakdown (Dollar Sales) of Coronary
Stents Market by Region in Europe for the Years 2008 & 2012
Table 36: Coronary Stents Market by Region in Europe:
2007-2015 (Sales in Thousand Units)
Table 37: Percentage Breakdown (Unit Sales) of Coronary Stents
Market by Region in Europe for the Years 2008 & 2012
Table 38: Coronary Stents Market by Segment in Europe:
2007-2015 (Sales in US$ Million)
Table 39: Percentage Breakdown (Dollar Sales) of Coronary
Stents Market by Segment in Europe for the Years 2008 & 2012
Table 40: Coronary Stents Market by Segment in Europe:
2007-2015 (Sales in Thousand Units)
Table 41: Percentage Breakdown (Unit Sales) of Coronary Stents
Market by Segment in Europe for the Years 2008 & 2012
Table 42: Coronary Stents Market by Segment in France:
2007-2015 (Sales in US$ Million)
Table 43: Percentage Breakdown (Dollar Sales) of Coronary
Stents Market by Segment in France for the Years 2008 & 2012
Table 44: Coronary Stents Market by Segment in France:
2007-2015 (Sales in Thousand Units)
Table 45: Percentage Breakdown (Unit Sales) of Coronary Stents
Market by Segment in France for the Years 2008 & 2012
Table 46: Coronary Stents Market by Segment in Germany:
2007-2015 (Sales in US$ Million)
Table 47: Percentage Breakdown (Dollar Sales) of Coronary
Stents Market by Segment in Germany for the Years 2008 & 2012
Table 48: Coronary Stents Market by Segment in Germany:
2007-2015 (Sales in Thousand Units)
Table 49: Percentage Breakdown (Unit Sales) of Coronary Stents
Market by Segment in Germany for the Years 2008 & 2012
Table 50: Coronary Stents Market by Segment in Italy:
2007-2015 (Sales in US$ Million)
Table 51: Percentage Breakdown (Dollar Sales) of Coronary
Stents Market by Segment in Italy for the Years 2008 & 2012
Table 52: Coronary Stents Market by Segment in Italy:
2007-2015 (Sales in Thousand Units)
Table 53: Percentage Breakdown (Unit Sales) of Coronary Stents
Market by Segment in Italy for the Years 2008 & 2012
Table 54: Coronary Stents Market by Segment in the UK:
2007-2015 (Sales in US$ Million)
Table 55: Percentage Breakdown (Dollar Sales) of Coronary
Stents Market by Segment in the UK for the Years 2008 & 2012
Table 56: Coronary Stents Market by Segment in the UK:
2007-2015 (Sales in Thousand Units)
Table 57: Percentage Breakdown (Unit Sales) of Coronary Stents
Market by Segment in the UK for the Years 2008 & 2012
Table 58: Coronary Stents Market by Segment in Spain:
2007-2015 (Sales in US$ Million)
Table 59: Percentage Breakdown (Dollar Sales) of Coronary
Stents Market by Segment in Spain for the Years 2008 & 2012
Table 60: Coronary Stents Market by Segment in Spain:
2007-2015 (Sales in Thousand Units)
Table 61: Percentage Breakdown (Unit Sales) of Coronary Stents
Market by Segment in Spain for the Years 2008 & 2012
Table 62: Coronary Stents Market by Segment in Russia:
2007-2015 (Sales in US$ Million)
Table 63: Percentage Breakdown (Dollar Sales) of Coronary
Stents Market by Segment in Russia for the Years 2008 & 2012
Table 64: Coronary Stents Market by Segment in Russia:
2007-2015 (Sales in Thousand Units)
Table 65: Percentage Breakdown (Unit Sales) of Coronary Stents
Market by Segment in Russia for the Years 2008 & 2012
Table 66: Coronary Stents Market by Segment in the Rest of
Europe: 2007-2015 (Sales in US$ Million)
Table 67: Percentage Breakdown (Dollar Sales) of Coronary
Stents Market by Segment in the Rest of Europe for the Years
2008 & 2012
Table 68: Coronary Stents Market by Segment in the Rest of
Europe: 2007- 2015 (Sales in Thousand Units)
Table 69: Percentage Breakdown (Unit Sales) of Coronary Stents
Market by Segment in the Rest of Europe for the Years 2008 &
2012
Table 70: Coronary Stents Market by Segment in Asia-Pacific:
2007-2015 (Sales in US$ Million)
Table 71: Percentage Breakdown (Dollar Sales) of Coronary
Stents Market by Segment in Asia-Pacific for the Years 2008 &
2012
Table 72: Coronary Stents Market by Segment in Asia-Pacific:
2007-2015 (Sales in Thousand Units)
Table 73: Percentage Breakdown (Unit Sales) of Coronary Stents
Market by Segment in Asia-Pacific for the Years 2008 & 2012
Table 74: Percentage Breakdown of Leading Coronary Stent
Manufacturer Value Sales in Rest of World - 2006
Table 75: Percentage Breakdown of Leading Coronary Stent
Manufacturer Unit Sales in Rest of World - 2006
Table 76: Coronary Stents Market by Segment in Rest of World:
2007-2015 (Sales in US$ Million)
Table 77: Percentage Breakdown (Dollar Sales) of Coronary
Stents Market by Segment in Rest of World for the Years 2008 &
2012
Table 78: Coronary Stents Market by Segment in Rest of World:
2007-2015 (Sales in Thousand Units)
Table 79: Percentage Breakdown (Unit Sales) of Coronary Stents
Market by Segment in Rest of World for the Years 2008 & 2012
COMPANIES PROFILED
To order this report:
Medical Equipment and Supply Industry: Coronary Stents - Global Market Trends
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Contact Nicolas Bombourg Reportlinker Email: [email protected] US: (805)652-2626 Intl: +1 805-652-2626
SOURCE Reportlinker
